FDA Proposes to Add Five Bulk Drug Substances to Compounding List

September 11, 2019

The FDA issued a proposed rule to include five new substances in its 503A bulk substances list for compounded drugs.

The five additions include glutaraldehyde, glycolic acid, L-citrulline, pyruvic acid, and trichloroacetic acid.

The agency selected the substances following reviews for safety and efficacy, as well as the historical use of the substance in compounded drugs.

View today's stories